ENTITY
Hua Medicine Ltd

Hua Medicine Ltd (2552 HK)

31
Analysis
Health CareChina
Hua Medicine operates as a drug development company. The Company develops and sells glucokinase activator and other products. Hua Medicine markets its products throughout China.
more
bearishMeituan
17 Sep 2018 06:37

Last Week in GER Research: Meituan, Nio, Haidilao, Shandong Gold, China Renais., X Financial and PDD

Below is a recap of the key IPO research produced by the Global Equity Research team. This week we dig into the economics of Mobike as it relates...

Logo
372 Views
Share
bullishNIO
15 Sep 2018 10:36

ECM Weekly (15 September 2018) - Fast & Furious - NIO, Qutoutiao, Haidilao, Viomi, X Financial

Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...

Share
bearishMeituan
10 Sep 2018 05:50

Last Week in GER Research: Meituan, China Tower, Haidilao, Qutoutiao, Hua Med., Chunlai, and Cootek

Below is a recap of the key IPO research produced by the Global Equity Research team. This week we assess Meituan's latest results ahead of its...

Logo
328 Views
Share
bullishMeituan
08 Sep 2018 13:18

ECM Weekly (8 September 2018) - Qutoutiao, Viomi, 111 Inc., Meituan, Haidilao

Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...

Share
03 Sep 2018 06:28

Hua Medicine IPO Preview: Suffering from the Ascletis Over-Valuation Syndrome

Hua Medicine Ltd (2552 HK) which specialises in developing drugs to treat Type 2 diabetes, is the third pre-profit biotech firm to IPO in Hong Kong...

Logo
792 Views
Share
x